PTEN hamartoma tumour syndrome: early tumour development in children

Patroula Smpokou1, Victor L Fox2, Wen-Hann Tan3

  • 1Division of Genetics & Metabolism, Children's National Health System, Washington, DC, USA George Washington University, School of Medicine and Health Sciences, Washington, DC, USA.

Insights

Children with PTEN hamartoma tumour syndrome (PHTS) can develop tumors at a young age. Early diagnosis of clinical findings and tumors is crucial for timely intervention and management in pediatric PHTS patients.

Area of Science:

  • Pediatric Oncology
  • Clinical Genetics
  • Rare Diseases

Background:

  • PTEN hamartoma tumour syndrome (PHTS) is a genetic disorder associated with an increased risk of various tumors.
  • Early identification of clinical manifestations and tumor development in children with PHTS is essential for proactive management.

Purpose of the Study:

  • To determine the earliest age of diagnosis for common clinical findings and tumors in pediatric patients diagnosed with PHTS.
  • To highlight characteristic early-onset features of PHTS in children.

Main Methods:

  • Retrospective review of medical records of 34 children diagnosed with PHTS (under 21 years old) at Boston Children's Hospital (1996-2011).
  • Data collected included growth parameters, clinical manifestations, tumor presence, and age at diagnosis.
  • Genetic testing confirmed PHTS diagnosis.

Main Results:

  • Macrocephaly and developmental/intellectual disability were common findings.
  • Pigmented penile macules were observed in all examined males.
  • Thyroid nodules diagnosed as early as 5 years, and thyroid carcinoma as early as 7 years.
  • Other tumors included renal cell carcinoma (11 years), ovarian granulosa cell tumor, and colonic ganglioneuroma (16 years).

Conclusions:

  • PHTS presents with characteristic clinical findings and tumors in childhood.
  • Tumorigenesis can occur at a young age in children with PHTS, underscoring the need for early and vigilant surveillance, particularly for thyroid abnormalities.
Abstract

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K